Skip to main content

Advertisement

Log in

Purtscher-like features in new-onset diabetic retinopathy

  • Case Report
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Agrawal A, McKibbin M (2007) Purtscher’s retinopathy: epidemiology, clinical features and outcome. Br J Ophthalmol 91(11):1456–1459. https://doi.org/10.1136/bjo.2007.117408

    Article  PubMed  PubMed Central  Google Scholar 

  2. Miguel AI, Henriques F, Azevedo LF, Loureiro AJ, Maberley DA (2013) Systematic review of Purtscher’s and Purtscher-like retinopathies. Eye (Lond) 27(1):1–13. https://doi.org/10.1038/eye.2012.222

    Article  CAS  Google Scholar 

  3. Ong T, Nolan W, Jagger J (2005) Purtscher-like retinopathy as an initial presentation of thrombotic thrombocytopenic purpura: a case report. Eye (Lond) 19(3):359–361. https://doi.org/10.1038/sj.eye.6701491

    Article  CAS  Google Scholar 

  4. Schroder S, Palinski W, Schmid-Schonbein GW (1991) Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 139(1):81–100

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Kuroda M, Nishida A, Kikuchi M, Kurimoto Y (2013) Purtscher’s retinopathy followed by neovascular glaucoma. Clin Ophthalmol 7:2235–2237. https://doi.org/10.2147/OPTH.S54231

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maria Vittoria Cicinelli.

Ethics declarations

Conflict of interest

MVC, MB, VS, RL declare that they have no conflict of interest. FB consultant for: Alcon (Fort Worth, Texas, USA), Alimera Sciences (Alpharetta, Georgia, USA), Allergan Inc (Irvine, California, USA), Farmila-Thea (Clermont-Ferrand, France), Bayer Shering-Pharma (Berlin, Germany), Bausch And Lomb (Rochester, New York, USA), Genentech (San Francisco, California, USA), Hoffmann-La-Roche (Basel, Switzerland), NovagaliPharma (Évry, France), Novartis (Basel, Switzerland), Sanofi-Aventis (Paris, France), Thrombogenics (Heverlee, Belgium), Zeiss (Dublin, USA).

Ethical approval

The study adhered to the 1964 Helsinki declaration and its later amendments.

Informed consent

Informed consent was obtained from the patient.

Additional information

Managed by Giuseppe Querques.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Battista, M., Cicinelli, M.V., Starace, V. et al. Purtscher-like features in new-onset diabetic retinopathy. Acta Diabetol 57, 377–379 (2020). https://doi.org/10.1007/s00592-019-01401-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-019-01401-x

Navigation